Kresmedsp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2022-04-20
Share capital
147,200.00 PLN
Registered address
ul. Wąska 15A, 15-481 Białystok, Poland
Email
Electronic delivery address
AE:PL-76684-11233-RIEUF-31
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 43 days early.
- 202523/04/2026
- 202425/06/2025
- 202311/06/2024
- 202212/06/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 568.40kMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD 142.52kMedianUSD 68.58AverageUSD 82.17k
Operating costs
This companyUSD 406.26kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 313.97kMedianUSD 119.88kAverageUSD 3.90m
Industry
Authorized Representatives
Anatoliusz Prochoruk – Management Board Member
Dariusz Prochoruk – President of the Management Board
Manner of representation
Each member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Anatoliusz Prochorukage 81 | 268 | – | 8.3437% |
Dariusz Prochorukage 55 | 2,676 | $36,142.63 | 90.8967% |
Others | 295 | $3,619.67 | 9.1033% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-04-12.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fibro-Labsp. z o.o. | $915,089.10 | fibro-lab.pl | ||
| EkoparkS.A. | $585,284.10 | eko-park.org | ||
| Centrum Badawczo-Rozwojowe Glokorsp. z o.o. | $551,349.36 | glokor.eu | ||
| Airway MedixS.A. | $512,838.82 | airway-medix.com | ||
| CTI Clinical Trial And Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | ||
| Etyka Ośrodek Badań Klinicznych Tomasz PestaS.K.A. | $514,414.85 | etykaosrodek.pl | ||
| Nanoo Printerssp. z o.o. | $150,791.60 | nanooprinters.eu | ||
| Solarstopsp. z o.o. | $65,910.57 | solarstop.pl | ||
| .Protsp. z o.o. | $34,756.89 | dotprot.com | ||
| EFMS.A. | $8,156.49 | engineers4medicine.com |
FAQ
The main business activity of Kresmed focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on April 20, 2022.
The headquarters is located at: ul. Wąska 15A, 15-481 Białystok.
The management board consists of: Anatoliusz Prochoruk (Member of the Management Board) and Dariusz Prochoruk (President of the Management Board).
The share capital of the company is PLN 147,200 (approx. $39,762).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $568,401 in 2025, which is an increase of 38.9% compared to 2024.
Yes, the company recorded a net profit of $142,525 in 2025, meaning the company increased its profit by 49.1%.
Last updated: 2026-10-07
